|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2009-2-27
|
|
pubmed:abstractText |
Mainly single-agent chemotherapy has been considered as standard treatment for elderly patients with non-small cell lung cancer (NSCLC). Docetaxel monotherapy is regarded as a standard treatment for elderly patients with advanced NSCLC, and recent subset analyses have suggested that platinum-based chemotherapy can be safely used in the elderly. This phase II study was conducted to evaluate the efficacy and safety of docetaxel and carboplatin in elderly patients with advanced NSCLC.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
1556-1380
|
|
pubmed:author |
pubmed-author:AsaiKazuhisaK,
pubmed-author:HirataKazutoK,
pubmed-author:IchimaruYukikazuY,
pubmed-author:KimuraTatsuoT,
pubmed-author:KodamaToyokiT,
pubmed-author:KudohShinzohS,
pubmed-author:KyohShigenoriS,
pubmed-author:MitsuokaShigekiS,
pubmed-author:TochinoYoshihiroY,
pubmed-author:YanaTakashiT,
pubmed-author:YoshimuraNaruoN
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
4
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
371-5
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:19155998-Age Factors,
pubmed-meshheading:19155998-Aged,
pubmed-meshheading:19155998-Aged, 80 and over,
pubmed-meshheading:19155998-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:19155998-Carboplatin,
pubmed-meshheading:19155998-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:19155998-Disease-Free Survival,
pubmed-meshheading:19155998-Dose-Response Relationship, Drug,
pubmed-meshheading:19155998-Drug Administration Schedule,
pubmed-meshheading:19155998-Female,
pubmed-meshheading:19155998-Follow-Up Studies,
pubmed-meshheading:19155998-Geriatric Assessment,
pubmed-meshheading:19155998-Humans,
pubmed-meshheading:19155998-Kaplan-Meier Estimate,
pubmed-meshheading:19155998-Lung Neoplasms,
pubmed-meshheading:19155998-Male,
pubmed-meshheading:19155998-Maximum Tolerated Dose,
pubmed-meshheading:19155998-Neoplasm Invasiveness,
pubmed-meshheading:19155998-Neoplasm Staging,
pubmed-meshheading:19155998-Prospective Studies,
pubmed-meshheading:19155998-Risk Assessment,
pubmed-meshheading:19155998-Survival Analysis,
pubmed-meshheading:19155998-Taxoids,
pubmed-meshheading:19155998-Treatment Outcome
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Phase II study of docetaxel and carboplatin in elderly patients with advanced non-small cell lung cancer.
|
|
pubmed:affiliation |
Department of Respiratory Medicine, Graduate School of Medicine, Osaka City University, Osaka, Japan. y-naruo@sc4.so-net.ne.jp
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial, Phase II
|
